HJA
PFE icon

Hugh Johnson Advisors’s Pfizer PFE Stock Holding History

Hugh Johnson Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.9M Buy
46,196
+4,426
+11% +$176K 0.59% 46
2019
Q1 		$1.68M Buy
41,770
+585
+1% +$23.4K 0.52% 47
2018
Q4 		$1.71M Sell
41,185
-432
-1% -$17.9K 0.63% 42
2018
Q3 		$1.74M Buy
41,617
+212
+0.5% +$8.16K 0.48% 51
2018
Q2 		$1.43M Buy
41,405
+1,674
+4% +$57.2K 0.41% 57
2018
Q1 		$1.34M Buy
39,731
+175
+0.4% +$6.02K 0.4% 60
2017
Q4 		$1.36M Sell
39,556
-543
-1% -$18.5K 0.4% 56
2017
Q3 		$1.36M Buy
40,099
+7,522
+23% +$242K 0.41% 56
2017
Q2 		$1.04M Buy
32,577
+933
+3% +$29.4K 0.33% 58
2017
Q1 		$1.03M Buy
31,644
+89
+0.3% +$2.81K 0.34% 61
2016
Q4 		$972K Sell
31,555
-1,615
-5% -$49.3K 0.34% 59
2016
Q3 		$1.07M Buy
33,170
+124
+0.4% +$4.15K 0.39% 58
2016
Q2 		$1.1M Buy
33,046
+65
+0.2% +$2.08K 0.43% 54
2016
Q1 		$927K Buy
32,981
+483
+1% +$13.8K 0.37% 56
2015
Q4 		$995K Sell
32,498
-231
-0.7% -$7.27K 0.38% 57
2015
Q3 		$975K Sell
32,729
-3,853
-11% -$124K 0.39% 57
2015
Q2 		$1.16M Sell
36,582
-140
-0.4% -$4.56K 0.41% 57
2015
Q1 		$1.21M Buy
36,722
+42
+0.1% +$1.33K 0.41% 58
2014
Q4 		$1.08M Sell
36,680
-97,091
-73% -$2.78M 0.38% 57
2014
Q3 		$3.75M Buy
133,771
+7,843
+6% +$220K 1.34% 33
2014
Q2 		$3.55M Buy
125,928
+284
+0.2% +$8.1K 1.3% 36
2014
Q1 		$3.83M Sell
125,644
-4,836
-4% -$144K 1.44% 30
2013
Q4 		$3.79M Buy
130,480
+16,043
+14% +$467K 1.49% 29
2013
Q3 		$3.12M Buy
114,437
+4,450
+4% +$121K 1.32% 33
2013
Q2 		$2.92M Buy
+109,987
New +$3.04M 1.33% 32

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hugh Johnson Advisors's PFE Position: Q2 2019 in Review

Hugh Johnson Advisors increased its Pfizer (PFE) stake by 11% in Q2 2019, buying an estimated $176K and bringing the position to 46,196 shares worth $1.9M. The position accounts for 0.59% of the portfolio, ranked #46.

Hugh Johnson Advisors first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. The position peaked at $3.83M in Q1 2014. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Hugh Johnson Advisors held 46,196 shares of Pfizer worth $1.9M as of Q2 2019.
  • Hugh Johnson Advisors bought 4,426 Pfizer shares in Q2 2019, an estimated $176K.
  • Pfizer made up 0.59% of Hugh Johnson Advisors's portfolio in Q2 2019, its #46 holding.
  • Hugh Johnson Advisors first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
  • Hugh Johnson Advisors's Pfizer position peaked at $3.83M in Q1 2014.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Hugh Johnson Advisors's 13F filing for Q2 2019, filed 6 Aug 2019.